Hypergonadotropic hypogonadism after ovarian tissue cryopreservation on a 13-year-old female: A case report and review of the literature.
Fiche du document
- doi: 10.1016/j.jogoh.2020.102029
- issn: 2468-7847
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jogoh.2020.102029
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33259962
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2468-7847
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_735D6D4A7CDF5
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Citer ce document
D. Moussaoui et al., « Hypergonadotropic hypogonadism after ovarian tissue cryopreservation on a 13-year-old female: A case report and review of the literature. », Serveur académique Lausannois, ID : 10.1016/j.jogoh.2020.102029
Métriques
Partage / Export
Résumé
Ovarian failure is a major long-term adverse event following gonadotoxic treatment of malignant diseases. Ovarian tissue cryopreservation can be offered in some conditions to preserve fertility. We report the case of a 13-year-old female with a diagnosis of acute myeloid leukemia, who presented with hypergonadotropic hypogonadism after unilateral ovariectomy for fertility preservation and before highly gonadotoxic treatment. Even though damage seemed only partial, this case suggests that the remaining contralateral ovarian function may be compromised after ovarian tissue cryopreservation, leading per se to a hypergonadotropic hypogonadism. Although indication of ovarian cryopreservation is not called into question in situations of highly gonadotoxic therapy, this procedure should only be performed after evaluation by a specialized multidisciplinary team and provided a solid indication.